Lung Diseases: Chronic Respiratory Infections (Record no. 46523)

MARC details
000 -LEADER
fixed length control field 02474naaaa2200337uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/52051
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220219215942.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number books978-3-03897-339-3
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783038973393
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783038973386
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/books978-3-03897-339-3
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Francesco B. Blasi (Ed.)
Relationship auth
245 10 - TITLE STATEMENT
Title Lung Diseases: Chronic Respiratory Infections
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. MDPI - Multidisciplinary Digital Publishing Institute
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (216 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. Both chronic and acute infections play a significant role in the pathogenesis and clinical course of chronic obstructive pulmonary disease (COPD) and both cystic fibrosis (CF) and non-CF bronchiectasis. There is also specific evidence that chronic infection, even in the absence of acute infection, has an influence on the manifestations and disease course. The infections found in COPD, CF, and bronchiectasis share a number of clinical similarities, the most striking of which are bacterial persistence despite the use of antibiotics and antibiotic resistance. In the last two decades, the rate of antibiotic resistance has increased dramatically and poses serious threats for patients and public health. There are different reasons for this increase in resistance, but the overuse of antibiotics in the community is certainly the most prominent. On the other hand, the chronic use of antibiotics in chronic diseases like COPD, CF, and bronchiectasis is also potentially associated with an increase in MDR pathogens. During the last decade, a growing interest has been raised in evaluating nontuberculous mycobacteria’s role in chronic respiratory diseases like bronchiectasis.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by-nc-nd/4.0/
Source of term cc
-- https://creativecommons.org/licenses/by-nc-nd/4.0/
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Fungi
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Non-Tuberculous Mycobacteria
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Antibiotics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Respiratory infections
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Pseudomonas aeruginosa
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Bronchiectasis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Microbiome
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://www.mdpi.com/books/pdfview/book/857">https://www.mdpi.com/books/pdfview/book/857</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/52051">https://directory.doabooks.org/handle/20.500.12854/52051</a>
Access status 0
Public note DOAB: description of the publication

No items available.